Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia

We report the results of a long-term follow-up series in our center to verify the impact of biologically effective dose (BED) on the efficacy and safety of Gamma Knife radiosurgery (GKS) in the treatment of primary trigeminal neuralgia (TN). A total of 138 consecutive cases of primary TN receiving G...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Deng, Yuan Gao, Yang Wu, Mengqi Wang, Linglong Xiao, Runlin Chen, Zhujun Zhang, Wei Pan, Wei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1614981/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225239179821056
author Hao Deng
Yuan Gao
Yuan Gao
Yang Wu
Mengqi Wang
Linglong Xiao
Runlin Chen
Zhujun Zhang
Wei Pan
Wei Pan
Wei Wang
Wei Wang
author_facet Hao Deng
Yuan Gao
Yuan Gao
Yang Wu
Mengqi Wang
Linglong Xiao
Runlin Chen
Zhujun Zhang
Wei Pan
Wei Pan
Wei Wang
Wei Wang
author_sort Hao Deng
collection DOAJ
description We report the results of a long-term follow-up series in our center to verify the impact of biologically effective dose (BED) on the efficacy and safety of Gamma Knife radiosurgery (GKS) in the treatment of primary trigeminal neuralgia (TN). A total of 138 consecutive cases of primary TN receiving GKS were included. A 4-mm collimator was used for all cases, and a median central dose of 85 Gy (range 70–90 Gy) was prescribed. The Barrow Neurological Institute Pain Scale was adopted to evaluate the severity of TN. The median follow-up period was 65.5 months (range 12–147 months). Overall, 123 (89.1%) patients eventually achieved effective relief. The influence of BED on treatment outcomes varied by target location. For patients with distal targets, BED was a significant predictor of treatment failure (OR: 0.996, 95% CI: 0.992–0.999, p = 0.02) and post-GKS complications (OR: 1.002, 95% CI: 1.000–1.004, p = 0.01). However, BED did not significantly influence outcomes in the proximal target subgroup, either for treatment failure or complications. No significant association was found between BED and long-term outcomes in the entire cohort or in any subgroup analysis. Adjusting GKS doses according to BED for the distal target may optimize clinical outcomes in TN patients.
format Article
id doaj-art-3b11e2f48a2746548db7c0e8369f3c5d
institution Kabale University
issn 1664-2295
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj-art-3b11e2f48a2746548db7c0e8369f3c5d2025-08-25T05:25:28ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-08-011610.3389/fneur.2025.16149811614981Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgiaHao Deng0Yuan Gao1Yuan Gao2Yang Wu3Mengqi Wang4Linglong Xiao5Runlin Chen6Zhujun Zhang7Wei Pan8Wei Pan9Wei Wang10Wei Wang11Department of Neurosurgery, West China Hospital, Chengdu, ChinaDepartment of Neurosurgery, West China Hospital, Chengdu, ChinaGamma Knife Center, West China Hospital, Chengdu, ChinaDepartment of Neurosurgery, West China Hospital, Chengdu, ChinaDepartment of Neurosurgery, West China Hospital, Chengdu, ChinaDepartment of Neurosurgery, West China Hospital, Chengdu, ChinaDepartment of Neurosurgery, West China Hospital, Chengdu, ChinaGamma Knife Center, West China Hospital, Chengdu, ChinaDepartment of Neurosurgery, West China Hospital, Chengdu, ChinaGamma Knife Center, West China Hospital, Chengdu, ChinaDepartment of Neurosurgery, West China Hospital, Chengdu, ChinaGamma Knife Center, West China Hospital, Chengdu, ChinaWe report the results of a long-term follow-up series in our center to verify the impact of biologically effective dose (BED) on the efficacy and safety of Gamma Knife radiosurgery (GKS) in the treatment of primary trigeminal neuralgia (TN). A total of 138 consecutive cases of primary TN receiving GKS were included. A 4-mm collimator was used for all cases, and a median central dose of 85 Gy (range 70–90 Gy) was prescribed. The Barrow Neurological Institute Pain Scale was adopted to evaluate the severity of TN. The median follow-up period was 65.5 months (range 12–147 months). Overall, 123 (89.1%) patients eventually achieved effective relief. The influence of BED on treatment outcomes varied by target location. For patients with distal targets, BED was a significant predictor of treatment failure (OR: 0.996, 95% CI: 0.992–0.999, p = 0.02) and post-GKS complications (OR: 1.002, 95% CI: 1.000–1.004, p = 0.01). However, BED did not significantly influence outcomes in the proximal target subgroup, either for treatment failure or complications. No significant association was found between BED and long-term outcomes in the entire cohort or in any subgroup analysis. Adjusting GKS doses according to BED for the distal target may optimize clinical outcomes in TN patients.https://www.frontiersin.org/articles/10.3389/fneur.2025.1614981/fullbiologically effective dosegamma knife radiosurgeryprimary trigeminal neuralgiapain reliefrecurrence
spellingShingle Hao Deng
Yuan Gao
Yuan Gao
Yang Wu
Mengqi Wang
Linglong Xiao
Runlin Chen
Zhujun Zhang
Wei Pan
Wei Pan
Wei Wang
Wei Wang
Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia
Frontiers in Neurology
biologically effective dose
gamma knife radiosurgery
primary trigeminal neuralgia
pain relief
recurrence
title Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia
title_full Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia
title_fullStr Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia
title_full_unstemmed Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia
title_short Differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia
title_sort differential impact of biologically effective dose in distal versus proximal gamma knife targets for trigeminal neuralgia
topic biologically effective dose
gamma knife radiosurgery
primary trigeminal neuralgia
pain relief
recurrence
url https://www.frontiersin.org/articles/10.3389/fneur.2025.1614981/full
work_keys_str_mv AT haodeng differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT yuangao differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT yuangao differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT yangwu differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT mengqiwang differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT linglongxiao differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT runlinchen differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT zhujunzhang differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT weipan differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT weipan differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT weiwang differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia
AT weiwang differentialimpactofbiologicallyeffectivedoseindistalversusproximalgammaknifetargetsfortrigeminalneuralgia